DIA 2017 Annual Meeting

Global drug development has long been an accepted practice and expectation for clinical research success. Despite the proliferation of technology and other industry innovations, success or failure still depends on a high performing team. Teams are increasingly spread out across the globe and in many cases working remotely which further challenges communication and direct collaboration. Still other challenges emerge when project teams are potentially comprised of representatives from the sponsor, contract research organizations (CROs) and independent contractors. This session will examine the role of the study start-up process, how to spot the early warning signs of dysfunction and practical strategies for how to best align and engage the global team.